No Data
Shanghai Fudan Invests in Ping An Bank Deposit
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - to Subscribe for Corporate Structured Deposit Product of Ping an Bank
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. subscribed for 0.2 billion yuan in Ping An Bank's structured deposit products.
Gelonghui reported on January 3 that Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that the company recently entered into an agreement with Ping An Bank for a structured deposit product, agreeing to purchase a structured deposit product from Ping An Bank using idle self-owned funds generated from daily operations, amounting to 0.2 billion yuan.
Ping An Bank: Supplementary Announcement to the 2023 Annual Report
Orient: The overall impact on banks' interest margins is manageable. In 2025, focus on improving risk expectations and the main line of recovery.
We are currently entering a period of intensive implementation of stable growth policies, with an expansion of mmf leading the way, followed closely by fiscal expansion, and a significant acceleration in local debts, profoundly impacting the fundamentals of banks in 2025.
Hu Yuefei has resigned as the chairman of Ping An Asset Management, officially bidding farewell to the Ping An Bank system, with at least 13 asset management subsidiaries' chairmen and presidents changing within the year.
① According to reports from the Financial Association, the board of directors of Ping An Assets Management Co., Ltd. received a written resignation letter from Hu Yuefei on November 18. ② Hu Yuefei is more familiar to the market as the former president of Ping An Bank. Including his experience at the predecessor of Ping An Bank, Shenzhen Development Bank, he has served in the Ping An Bank system for over 30 years. ③ At least 13 asset management companies have experienced significant personnel changes this year.
